<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>CRYSTAL EQUITY RESEARCH - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/81891.xml</link>
<description>CRYSTAL EQUITY RESEARCH - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>Crystal Equity Research Initiates Coverage of Hi-Tech Pharmacal Company, Inc.</title>
     <link>http://www.prweb.com/releases/2006/03/prweb362853.htm</link><description>   <![CDATA[ <P>Crystal Equity Research, LLC initiated coverage of HI-TECH PHARMACAL COMPANY, INC. (HITK: Nasdaq) with a Buy rating based on Hi-Tech Pharmacal&#8217;s building market position and healthy cash flow generation.  The Company appears to have found the right level of specialization and focus to capture market share in the highly competitive generic drug space.   The full report on Hi-Tech Pharmacal is available at www.crystalequityresearch.com. (PRWeb Mar 25, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/03/prweb362853.htm">http://www.prweb.com/releases/2006/03/prweb362853.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2006/03/prweb362853.htm</guid>
        </item>
</channel>
</rss>